|
1
|
Saklayen MG: The global epidemic of the
metabolic syndrome. Curr Hypertens Rep. 20(12)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Adambekov S, Yi Y, Fabio A, Miljkovic I,
Edwards RP, Lopa S and Linkov F: Metabolic syndrome in endometrial
cancer patients: Systematic review. Metab Syndr Relat Disord.
17:241–249. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Alberti KG, Eckel RH, Grundy SM, Zimmet
PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith
SC Jr, et al: Harmonizing the metabolic syndrome: A joint interim
statement of the International Diabetes Federation Task Force on
Epidemiology and Prevention; National Heart, Lung, and Blood
Institute; American Heart Association; World Heart Federation;
International Atherosclerosis Society; and International
Association for the Study of Obesity. Circulation. 120:1640–1645.
2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Park Y-W, Zhu S, Palaniappan L, Heshka S,
Carnethon MR and Heymsfield SB: The metabolic syndrome: Prevalence
and associated risk factor findings in the US population from the
Third National Health and Nutrition Examination Survey, 1988-1994.
Arch Intern Med. 163:427–436. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Alberti KG, Zimmet P and Shaw J: IDF
Epidemiology Task Force Consensus Group. The metabolic syndrome - a
new worldwide definition. Lancet. 366:1059–1062. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rajput R, Rajput M, Mishra S and Ahlawat
P: Prevalence of metabolic syndrome in prediabetes. Metab Syndr
Relat Disord. 17:406–410. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Popa AR, Bungau S, Vesa CM, Bondar AC,
Pantis C, Maghiar O, Dimulescu (Nica) IA, Nistor Cseppento DC and
Rus M: Evaluating the efficacy of the treatment with benfotiamine
and alpha-lipoic acid in distal symmetric painful diabetic
polyneuropathy. Rev Chim. 70:3108–3114. 2019.
|
|
8
|
Xu H, Li X, Adams H, Kubena K and Guo S:
Etiology of metabolic syndrome and dietary intervention. Int J Mol
Sci. 20(E128)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lau DC, Dhillon B, Yan H, Szmitko PE and
Verma S: Adipokines: Molecular links between obesity and
atheroslcerosis. Am J Physiol Heart Circ Physiol. 288:H2031–H2041.
2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Festa A, D'Agostino R Jr, Howard G,
Mykkänen L, Tracy RP and Haffner SM: Chronic subclinical
inflammation as part of the insulin resistance syndrome: The
Insulin Resistance Atherosclerosis Study (IRAS). Circulation.
102:42–47. 2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Saito M, Ishimitsu T, Minami J, Ono H,
Ohrui M and Matsuoka H: Relations of plasma high-sensitivity
C-reactive protein to traditional cardiovascular risk factors.
Atherosclerosis. 167:73–79. 2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Suzuki T, Voeks J, Zakai NA, Jenny NS,
Brown TM, Safford MM, LeWinter M, Howard G and Cushman M: Metabolic
syndrome, C-reactive protein, and mortality in U.S. Blacks and
Whites: The reasons for geographic and racial differences in stroke
(REGARDS) study. Diabetes Care. 37:2284–2290. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Khera A, Vega GL, Das SR, Ayers C, McGuire
DK, Grundy SM and de Lemos JA: Sex differences in the relationship
between C-reactive protein and body fat. J Clin Endocrinol Metab.
94:3251–3258. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Devaraj S, Singh U and Jialal I: Human
C-reactive protein and the metabolic syndrome. Curr Opin Lipidol.
20:182–189. 2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mori Y, Otabe S, Dina C, Yasuda K,
Populaire C, Lecoeur C, Vatin V, Durand E, Hara K, Okada T, et al:
Genome-wide search for type 2 diabetes in Japanese affected
sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and
identifies two new candidate loci on 7p and 11p. Diabetes.
51:1247–1255. 2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yamauchi T, Kamon J, Ito Y, Tsuchida A,
Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et
al: Cloning of adiponectin receptors that mediate antidiabetic
metabolic effects. Nature. 423:762–769. 2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sanjari M, Khodashahi M, Gholamhoseinian A
and Shokoohi M: Association of adiponectin and metabolic syndrome
in women. J Res Med Sci. 16:1532–1540. 2011.PubMed/NCBI
|
|
18
|
Yamauchi T, Kamon J, Minokoshi Y, Ito Y,
Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al:
Adiponectin stimulates glucose utilization and fatty-acid oxidation
by activating AMP-activated protein kinase. Nat Med. 8:1288–1295.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Achari AE and Jain SK: Adiponectin, a
therapeutic target for obesity, diabetes, and endothelial
dysfunction. Int J Mol Sci. 18(E1321)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Abdel-Daim MM, El-Tawil OS, Bungau SG and
Atanasaov AG: Applications of antioxidants in metabolic disorders
and degenerative diseases: Mechanistic approach. Oxid Med Cell
Longev. 2019(4179676)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Abdel-Daim MM, Zakhary NI, Aleya L, Bungau
SG, Bohara RA and Siddiqi NJ: Aging, metabolic, and degenerative
disorders: Biomedical value of antioxidants. Oxid Med Cell Longev.
2018(2098123)2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Popa AR, Vesa CM, Uivarosan D, Jurca CM,
Isvoranu G, Socea B, Stanescu AMA, Iancu MA, Scarneciu I and Zaha
DC: Cross-sectional study regarding the association between
sweetened beverages intake, fast-food products, body mass index,
fasting blood glucose and blood pressure in the young adults from
North-western Romania. Rev Chim. 70:156–160. 2019.
|
|
23
|
Grigore O, Mihailescu AI, Solomon I, Boda
D and Caruntu C: Role of stress in modulation of skin neurogenic
inflammation. Exp Ther Med. 17:997–1003. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ghita MA, Caruntu C, Lixandru D, Pitea A,
Batani A and Boda D: The quest for novel biomarkers in early
diagnosis of diabetic neuropathy. Curr Proteomics. 14:86–99.
2017.
|
|
25
|
Gabor-Harosa FM, Stan OP, Daina L and
Mocean F: Proposed model for a Romanian register of chronic
diseases in children. Comput Methods Programs Biomed. 130:198–204.
2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Koh SB, Yoon J, Kim JY, Yoo BS, Lee SH,
Park JK and Choe KH: Relationships between serum adiponectin with
metabolic syndrome and components of metabolic syndrome in
non-diabetic Koreans: ARIRANG study. Yonsei Med J. 52:234–241.
2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
von Frankenberg AD, do Nascimento FV,
Gatelli LE, Nedel BL, Garcia SP, de Oliveira CSV, Saddi-Rosa P,
Reis AF, Canani LH and Gerchman F: Major components of metabolic
syndrome and adiponectin levels: A cross-sectional study. Diabetol
Metab Syndr. 6(26)2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Deepa SS, Zhou L, Ryu J, Wang C, Mao X, Li
C, Zhang N, Musi N, DeFronzo RA, Liu F, et al: APPL1 mediates
adiponectin-induced LKB1 cytosolic localization through the
PP2A-PKCzeta signaling pathway. Mol Endocrinol. 25:1773–1785.
2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nigro E, Scudiero O, Monaco ML, Palmieri
A, Mazzarella G, Costagliola C, Bianco A and Daniele A: New insight
into adiponectin role in obesity and obesity-related diseases.
Biomed Res Int. 2014(658913)2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ding YS, Guo SX, Ma RL, Li SG, Guo H,
Zhang JY, Zhang M, Liu JM, He J, Yan YZ, et al: Association of
metabolic syndrome with the adiponectin to homeostasis model
assessment of insulin resistance ratio. Mediators Inflamm.
2015(607364)2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Huffman FG, Gomez GP and Zarini GG:
Metabolic syndrome and high-sensitivity C-reactive protein in
Cubans. Ethn Dis. 19:115–120. 2009.PubMed/NCBI
|
|
32
|
den Engelsen C, Koekkoek PS, Gorter KJ,
van den Donk M, Salomé PL and Rutten GE: High-sensitivity
C-reactive protein to detect metabolic syndrome in a centrally
obese population: A cross-sectional analysis. Cardiovasc Diabetol.
11(25)2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Abdella NA, Mojiminiyi OA, Moussa MA, Zaki
M, Al Mohammedi H, Al Ozairi ES and Al Jebely S: Plasma leptin
concentration in patients with type 2 diabetes: Relationship to
cardiovascular disease risk factors and insulin resistance. Diabet
Med. 22:278–285. 2005.PubMed/NCBI View Article : Google Scholar
|
|
34
|
López-Jaramillo P, Gómez-Arbeláez D,
López-López J, López-López C, Martínez-Ortega J, Gómez-Rodríguez A
and Triana-Cubillos S: The role of leptin/adiponectin ratio in
metabolic syndrome and diabetes. Horm Mol Biol Clin Investig.
18:37–45. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Takahashi M, Arita Y, Yamagata K,
Matsukawa Y, Okutomi K, Horie M, Shimomura I, Hotta K, Kuriyama H,
Kihara S, et al: Genomic structure and mutations in
adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord.
24:861–868. 2000.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ilie MA, Caruntu C, Tampa M, Georgescu SR,
Matei C, Negrei C, Ion RM, Constantin C, Neagu M and Boda D:
Capsaicin: Physicochemical properties, cutaneous reactions and
potential applications in painful and inflammatory conditions. Exp
Ther Med. 18:916–925. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ghiţă MA, Căruntu C, Rosca AE, Căruntu A,
Moraru L, Constantin C, Neagu M and Boda D: Real-time investigation
of skin blood flow changes induced by topical capsaicin. Acta
Dermatovenerol Croat. 25:223–227. 2017.PubMed/NCBI
|
|
38
|
Caruntu C, Boda D, Constantin C, Caruntu A
and Neagu M: Catecholamines increase in vitro proliferation of
murine B16F10 melanoma cells. Acta Endocrinol (Copenh). 10:545–558.
2014.
|
|
39
|
Kriketos AD, Gan SK, Poynten AM, Furler
SM, Chisholm DJ and Campbell LV: Exercise increases adiponectin
levels and insulin sensitivity in humans. Diabetes Care.
27:629–630. 2004.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ohashi K, Kihara S, Ouchi N, Kumada M,
Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N, et al:
Adiponectin replenishment ameliorates obesity-related hypertension.
Hypertension. 47:1108–1116. 2006.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Unamuno X, Izaguirre M, Gómez-Ambrosi J,
Rodríguez A, Ramírez B, Becerril S, Valentí V, Moncada R, Silva C,
Salvador J, et al: Increase of the Adiponectin/leptin ratio in
patients with obesity and type 2 diabetes after Roux-en-Y gastric
bypass. Nutrients. 11(2069)2019.PubMed/NCBI View Article : Google Scholar
|
